XML 62 R49.htm IDEA: XBRL DOCUMENT v3.22.1
COMMITMENTS AND CONTINGENT LIABILITIES - Additional (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2021
USD ($)
shares
Commitments And Contingencies Line Items  
Bank guarantee $ 618
Royalty rate 7.00%
Net sales of Company products sold by Company's licensees  
Commitments And Contingencies Line Items  
Royalty payment as a percentage of grants 0.65%
Israeli Innovation Authority (IIA)  
Commitments And Contingencies Line Items  
Grant income $ 4,065
Royalty expense 0
Liabilities assumed $ 5,061
Israeli Innovation Authority (IIA) | Future sales of developed product  
Commitments And Contingencies Line Items  
Royalty payment as a percentage of grants 100.00%
Israeli Innovation Authority (IIA) | Minimum | Future sales of developed product  
Commitments And Contingencies Line Items  
Royalty rate 3.00%
Israeli Innovation Authority (IIA) | Maximum | Future sales of developed product  
Commitments And Contingencies Line Items  
Royalty rate 3.50%
Althera  
Commitments And Contingencies Line Items  
Liabilities assumed $ 474
Potential payment $ 1,500
Althera | Future gross revenues derived from purchased intellectual property  
Commitments And Contingencies Line Items  
Royalty rate 2.00%
Ramot | Net sales of all of the Company's products  
Commitments And Contingencies Line Items  
Royalty rate 2.50%
HekaBio K.K.  
Commitments And Contingencies Line Items  
Milestone number of ordinary stock options | shares 271,588
Stock option exercise price 4.42%
HekaBio K.K. | Reimbursement Price  
Commitments And Contingencies Line Items  
Royalty rate 3.50%
HekaBio K.K. | Revenue from distribution receipts  
Commitments And Contingencies Line Items  
Royalty rate 10.00%
BGN Technologies | Sales of alpha radiation products  
Commitments And Contingencies Line Items  
Royalty rate 0.75%
BGN Technologies | Sales of product containing intellectual property  
Commitments And Contingencies Line Items  
Royalty rate 1.50%
BGN Technologies | License revenue related to jointly developed intellectual property  
Commitments And Contingencies Line Items  
Royalty rate 4.00%
BGN Technologies | License revenue related to intellectual property  
Commitments And Contingencies Line Items  
Royalty rate 8.00%
Cambridge University Hospitals NHS Trust | Revenue generated from patent  
Commitments And Contingencies Line Items  
Royalty rate 5.00%
Cambridge University Hospitals NHS Trust | Net sales of treatment for Squamous Cell Carcinoma  
Commitments And Contingencies Line Items  
Royalty rate 2.00%